# Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease

> **NCT06207331** · NA · TERMINATED · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 6 (actual)

## Conditions studied

- Respiratory Function Tests
- Chronic Obstructive Pulmonary Disease
- Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine 0.5 μg/kg
- **DRUG:** Dexmedetomidine 1 μg/kg
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06207331
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-28
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** no patient enrolled.
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207331, "Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06207331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*